Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Sep 22;218(9):1517-1518.
doi: 10.1093/infdis/jiy363.

Levonorgestrel and Female Genital Tract Immunity: Time for a Closer Look

Rodolfo D Vicetti Miguel  1 , Nirk E Quispe Calla  1 , Thomas L Cherpes  1
Affiliations
Comment

Levonorgestrel and Female Genital Tract Immunity: Time for a Closer Look

Rodolfo D Vicetti Miguel et al. J Infect Dis. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Levonorgestrel (LNG) increases mouse susceptibility to genital Chlamydia trachomatis infection. Untreated mice in estrus and LNG-treated mice were intravaginally inoculated with 104 inclusion-forming units of C. trachomatis serovar D elementary bodies. Cervicovaginal lavages (CVL) were obtained at indicated time points, and C. trachomatis DNA levels were measured by quantitative reverse transcription polymerase chain reaction analysis. The left panel shows C. trachomatis DNA levels, and the right panel depicts total C. trachomatis load calculated as area under the curve (AUC) of each animal. Displayed data were pooled from 2 independent experiments with 5 animals per group in each experiment. Values are median (range). ND, nondetectable.
See this image and copyright information in PMC

Comment on

References

    1. Eastman AJ, Bergin IL, Chai D, et al. . Impact of the levonorgestrel-releasing intrauterine system on the progression of chlamydia trachomatis infection to pelvic inflammatory disease in a baboon model. J Infect Dis 2018; 217:656–66. - PMC - PubMed
    1. Liechty ER, Bergin IL, Bassis CM, et al. . The levonorgestrel-releasing intrauterine system is associated with delayed endocervical clearance of Chlamydia trachomatis without alterations in vaginal microbiota. Pathog Dis 2015; 73:ftv070. - PMC - PubMed
    1. Lekovich JP, Amrane S, Pangasa M, et al. . Comparison of human papillomavirus infection and cervical cytology in women using copper-containing and levonorgestrel-containing intrauterine devices. Obstet Gynecol 2015; 125:1101–5. - PubMed
    1. Quispe Calla NE, Vicetti Miguel RD, Mei A, Fan S, Gilmore JR, Cherpes TL. Dendritic cell function and pathogen-specific T cell immunity are inhibited in mice administered levonorgestrel prior to intranasal Chlamydia trachomatis infection. Sci Rep 2016; 6:37723. - PMC - PubMed
    1. Hall OJ, Klein SL. Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites. Mucosal Immunol 2017; 10:1097–107. - PubMed